Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04981392 · ClinicalTrials.gov registry record · NA
Trusted Messengers: Intervention to Promote COVID-19 Vaccination
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 21,844
- Enrollment target
NCT04981392 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 21,844 participants.
The verdict
NCT04981392, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,844 participants
- Enrollment target
Study Summary
The study aims to assess the impact of a multicomponent intervention to support Primary Care Provider (PCP) outreach to promote COVID-19 vaccination among vulnerable patients in and near Worcester, MA via a pragmatic, cluster randomized trial.
Interventions
- BEHAVIORAL Primary care text message outreach to unvaccinated patients and resources to support PCPs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,844 participants |
| Start Date | 2022-06-02 |
| Est. Completion | 2023-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04981392
The ClinicalTrials.gov registry entry for NCT04981392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21,844 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Primary care text message outreach to unvaccinated patients and resources to support PCPs is the first listed.
NCT04981392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04981392 about?
NCT04981392 is a clinical study titled "Trusted Messengers: Intervention to Promote COVID-19 Vaccination". The study aims to assess the impact of a multicomponent intervention to support Primary Care Provider (PCP) outreach to promote COVID-19 vaccination among vulnerable patients in and near Worcester, MA via a pragmatic, cluster randomized trial.
What is the current status of trial NCT04981392?
This trial is currently completed. It is a NA study. The enrollment target is 21,844 participants. The study started on 2022-06-02. Estimated completion is 2023-10-25.
What interventions are being tested in trial NCT04981392?
The interventions under investigation include: Primary care text message outreach to unvaccinated patients and resources to support PCPs (BEHAVIORAL).
Who is sponsoring clinical trial NCT04981392?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.